Fluoxetine (FLU), a selective serotonin reuptake inhibitor, is widely prescribed in the treatment of major depressive disorder
GLP-1 weight-loss medications are changing how people approach food and drink
The dye methylene blue will oxidise NADPH
Protocol 1: the slow and steady semaglutide escalation Goal: Minimize side effects while reaching effective therapeutic levels Schedule: Weeks 1-6: 0.25 mg weekly (extended from standard 4 weeks) Weeks 7-12: 0.5 mg weekly (extended) Weeks 13-16: 1.0 mg weekly Weeks 17-20: 1.7 mg weekly Week 21+: 2.4 mg maintenance Why the plotter supports this: By extending the initial low-dose phases to six weeks instead of four, you ensure complete steady state establishment before escalation
For Clinicians: Maintain evidence-based practice, avoid hype
For pediatric patients, a study investigating liraglutide treatment in a male with a homozygous LOF MC4R variant (c.750_751del p.Ile251fsTer34) - accompanied by severe insulin resistance, non-alcoholic fatty liver disease, and obstructive sleep apnea - has also indicated therapeutic benefits [69]